Literature DB >> 19234524

YEATS domain proteins: a diverse family with many links to chromatin modification and transcription.

Julia M Schulze1, Alice Y Wang, Michael S Kobor.   

Abstract

Chromatin modifications play crucial roles in various biological processes. An increasing number of conserved protein domains, often found in multisubunit protein complexes, are involved in establishing and recognizing different chromatin modifications. The YEATS domain is one of these domains, and its role in chromatin modifications and transcription is just beginning to be appreciated. The YEATS domain family of proteins, conserved from yeast to human, contains over 100 members in more than 70 eukaryotic species. Yaf9, Taf14, and Sas5 are the only YEATS domain proteins in Saccharomyces cerevisiae. Human YEATS domain family members, such as GAS41, ENL, and AF9, have a strong link to cancer. GAS41 is amplified in glioblastomas and astrocytomas; ENL and AF9 are among the most frequent translocation partners of the mixed lineage leukemia (MLL) gene. This review will focus on the best characterized YEATS proteins, discuss their diverse roles, and reflect potential functions of the YEATS domain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19234524     DOI: 10.1139/O08-111

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  64 in total

1.  Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis.

Authors:  Man Mohan; Chengqi Lin; Erin Guest; Ali Shilatifard
Journal:  Nat Rev Cancer       Date:  2010-09-16       Impact factor: 60.716

Review 2.  Reading chromatin: insights from yeast into YEATS domain structure and function.

Authors:  Julia M Schulze; Alice Y Wang; Michael S Kobor
Journal:  Epigenetics       Date:  2010-10-01       Impact factor: 4.528

3.  Targeting recruitment of disruptor of telomeric silencing 1-like (DOT1L): characterizing the interactions between DOT1L and mixed lineage leukemia (MLL) fusion proteins.

Authors:  Chenxi Shen; Stephanie Y Jo; Chenzhong Liao; Jay L Hess; Zaneta Nikolovska-Coleska
Journal:  J Biol Chem       Date:  2013-09-01       Impact factor: 5.157

Review 4.  Pharmacogenomics of hypertension and heart disease.

Authors:  Meghan J Arwood; Larisa H Cavallari; Julio D Duarte
Journal:  Curr Hypertens Rep       Date:  2015-09       Impact factor: 5.369

5.  The FRIGIDA complex activates transcription of FLC, a strong flowering repressor in Arabidopsis, by recruiting chromatin modification factors.

Authors:  Kyuha Choi; Juhyun Kim; Hyun-Ju Hwang; Sanghee Kim; Chulmin Park; Sang Yeol Kim; Ilha Lee
Journal:  Plant Cell       Date:  2011-01-31       Impact factor: 11.277

6.  HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP.

Authors:  Bijan Sobhian; Nadine Laguette; Ahmad Yatim; Mirai Nakamura; Yves Levy; Rosemary Kiernan; Monsef Benkirane
Journal:  Mol Cell       Date:  2010-05-14       Impact factor: 17.970

7.  YEATS4 is a novel oncogene amplified in non-small cell lung cancer that regulates the p53 pathway.

Authors:  Larissa A Pikor; William W Lockwood; Kelsie L Thu; Emily A Vucic; Raj Chari; Adi F Gazdar; Stephen Lam; Wan L Lam
Journal:  Cancer Res       Date:  2013-10-29       Impact factor: 12.701

8.  The GAS41-PP2Cbeta complex dephosphorylates p53 at serine 366 and regulates its stability.

Authors:  Jeong Hyeon Park; Rebecca J Smith; Sheau-Yann Shieh; Robert G Roeder
Journal:  J Biol Chem       Date:  2011-02-11       Impact factor: 5.157

9.  Identification of Uncharacterized Components of Prokaryotic Immune Systems and Their Diverse Eukaryotic Reformulations.

Authors:  A Maxwell Burroughs; L Aravind
Journal:  J Bacteriol       Date:  2020-11-19       Impact factor: 3.490

10.  Asf1-like structure of the conserved Yaf9 YEATS domain and role in H2A.Z deposition and acetylation.

Authors:  Alice Y Wang; Julia M Schulze; Emmanuel Skordalakes; Jennifer W Gin; James M Berger; Jasper Rine; Michael S Kobor
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.